A new method for detecting bowel cancer is more than 90% accurate at predicting which higher-risk people will develop the disease, according to research. About 500,000 people in the UK live with inflammatory bowel disease (IBD), including Crohn's and ulcerative colitis.

A new DNA test developed in the UK can accurately predict whether high-risk patients will develop colorectal cancer in the five years. People with inflammatory bowel disease (IBD) — which includes conditions like ulcerative colitis and Crohn’s — are up to four times more likely to get this type of cancer,

Experts hope to create a blood test to see which patients with inflammatory bowel disease are most at risk of bowel cancer.